×
About 34,705 results

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global...
https://doi.org/10.1016/j.kint.2022.03.019
Kidney International;

Apr 24th, 2022 - Numerous genes for monogenic kidney diseases with classical patterns of inheritance, as well as genes for complex kidney diseases that manifest in combination with environmental factors, have been discovered. Genetic findings are increasingly used to inform clinical management of nephropathies, and have led to improved diagnostics, disease surveillance, choice of therapy, and family counseling....

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: A...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029123
Current Oncology (Toronto, Ont.); Blanchette P, Sivajohanathan D et. al.

Apr 22nd, 2022 - The purpose of this guideline is to determine the clinical utility of multigene profiling assays in individuals with early-stage invasive breast cancer. This guideline was developed by Ontario Health (Cancer Care Ontario)'s Program in Evidence-Based Care (PEBC) through a systematic review of relevant literature, patient- and caregiver-specific consultation and internal and external reviews. Rec...

Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019936
Orphanet Journal of Rare Diseases; Mosbah H, Donadille B et. al.

Apr 21st, 2022 - Dunnigan syndrome, or Familial Partial Lipodystrophy type 2 (FPLD2; ORPHA 2348), is a rare autosomal dominant disorder due to pathogenic variants of the LMNA gene. The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins), is to provide health professionals with a guide to optimal management and care of patients with FPLD2, based on a ...

KASL clinical practice guidelines for management of chronic hepatitis B.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;

Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,

Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis...
https://doi.org/10.1016/j.hrthm.2022.02.022
Heart Rhythm; Sandhu RK, Seiler A et. al.

Apr 17th, 2022 - An integrated, coordinated, and patient-centered approach to atrial fibrillation (AF) care delivery may improve outcomes and reduce cost. The purpose of this study was to gain a better understanding from key stakeholder groups on current practices, needs, and potential barriers to implementing optimal integrated AF care. A series of comprehensive questionnaires were designed by the Heart Rhythm...

Guideline No. 425a: Cannabis Use Throughout Women's Lifespans - Part 1: Fertility, Cont...
https://doi.org/10.1016/j.jogc.2022.01.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use with respect to women's health. Areas of focus include general patterns of cannabis use as well as safety of use; care for women who use cannabis; stigma; screening, brief intervention, and referral to treatment; impact on hormonal regulation; reproductive health, including contraception and fertility; sexual function; effe...

Directive clinique no 425a : Le cannabis aux différentes périodes de la vie des femmes ...
https://doi.org/10.1016/j.jogc.2022.02.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Robert M, Graves LE et. al.

Apr 12th, 2022 - Fournir aux fournisseurs de soins de santé les meilleures données probantes sur l'utilisation de cannabis et la santé des femmes. Les domaines d'intérêt sont : les profils généraux d'utilisation du cannabis ainsi que la sécurité de la consommation; les soins aux femmes qui utilisent le cannabis; la stigmatisation; le dépistage, l'intervention brève et l'orientation vers le traitement; les effet...

Directive clinique no 425b : Le cannabis aux différentes périodes de la vie des femmes ...
https://doi.org/10.1016/j.jogc.2022.02.012
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Graves LE, Robert M et. al.

Apr 12th, 2022 - Fournir aux fournisseurs de soins les meilleures données probantes sur l'utilisation de cannabis et la santé des femmes. Les domaines d'intérêt sont le dépistage, la dépendance et le sevrage; la communication et la tenue de dossier; la grossesse (y compris les issues fœtales et maternelles); la gestion de la douleur maternelle; les soins postnataux (y compris la fumée secondaire et la parentali...

Guideline No. 425b: Cannabis Use Throughout Women's Lifespans - Part 2: Pregnancy, the ...
https://doi.org/10.1016/j.jogc.2022.01.013
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Graves LE, Robert M et. al.

Apr 12th, 2022 - To provide health care providers with the best evidence on cannabis use and women's health. Areas of focus include screening, dependence, and withdrawal; communication and documentation; pregnancy (including maternal and fetal outcomes); maternal pain control; postpartum care (including second-hand smoking and parenting); and breastfeeding. The target population includes women who are planning ...

Return to Work for People With Aphasia.
https://doi.org/10.1016/j.apmr.2021.12.020
Archives of Physical Medicine and Rehabilitation; Gilmore N

Apr 9th, 2022 - Return to Work for People With Aphasia.|2022|Gilmore N,|

Measurement of lysosomal enzyme activities: A technical standard of the American Colleg...
https://doi.org/10.1016/j.gim.2021.12.013
Genetics in Medicine : Official Journal of the American C... Strovel ET, Cusmano-Ozog K et. al.

Apr 9th, 2022 - Assays that measure lysosomal enzyme activity are important tools for the screening and diagnosis of lysosomal storage disorders (LSDs). They are often ordered in combination with urine oligosaccharide and glycosaminoglycan analysis, additional biomarker assays, and/or DNA sequencing when an LSD is suspected. Enzyme testing in whole blood/leukocytes, serum/plasma, cultured fibroblasts, or dried...

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart ...
https://doi.org/10.1016/j.hrthm.2022.03.1225
Heart Rhythm; Wilde AAM, Semsarian C et. al.

Apr 8th, 2022 - European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases.|2022|Wilde AAM,Semsarian C,Márquez MF,Sepehri Shamloo A,Ackerman MJ,|

Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association...
https://doi.org/10.1016/j.echo.2021.12.012
Journal of the American Society of Echocardiography : Off... Edvardsen T, Asch FM et. al.

Apr 6th, 2022 - Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.|2022|Edvardsen T,Asch FM,Davidson B,Delgado V,DeMaria A,|

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the Americ...
https://doi.org/10.1016/j.jacc.2021.12.012
Journal of the American College of Cardiology; Heidenreich PA, Bozkurt B et. al.

Apr 6th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart...

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A R...
https://doi.org/10.1016/j.jacc.2021.12.011
Journal of the American College of Cardiology; Heidenreich PA, Bozkurt B et. al.

Apr 6th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart...

Canadian Society of Clinical Chemists (CSCC) Harmonized Clinical Laboratory Lipid Repor...
https://doi.org/10.1016/j.cjca.2022.03.019
The Canadian Journal of Cardiology; White-Al Habeeb NMA, Higgins V et. al.

Apr 5th, 2022 - There is limited guidance on laboratory reporting and interpretation of lipids and lipoproteins used in cardiovascular risk stratification. This contributes to inconsistencies in lipid reporting across clinical laboratories. Recently, the Canadian Cardiovascular Society (CCS) published the 2021 CCS Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the...

ISHLT position paper on thoracic organ transplantation in controlled donation after cir...
https://doi.org/10.1016/j.healun.2022.03.005
The Journal of Heart and Lung Transplantation : the Offic... Holm AM, Courtwright A et. al.

Apr 5th, 2022 - Controlled organ donation after circulatory determination of death is increasingly being used for the donation of organs also in thoracic transplantation. This document outlines the position of the International Society for Heart and Lung Transplantation on thoracic organ transplantation in circulatory determination of death. The document also includes a position regarding some of the methods a...

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
https://doi.org/10.1016/j.cardfail.2022.02.010
Journal of Cardiac Failure; ,

Apr 5th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart...

Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV...
https://doi.org/10.1016/j.athoracsur.2022.01.018
The Annals of Thoracic Surgery; Simonato M, Vemulapalli S et. al.

Apr 4th, 2022 - Transcatheter aortic valve replacement (TAVR) is the standard of care for severe, symptomatic aortic stenosis. Real-world TAVR data collection contributes to benefit/risk assessment and safety evidence for the U.S. Food and Drug Administration, quality evaluation for the Centers for Medicare and Medicaid Services and hospitals, as well as clinical research and real-world implementation through ...

Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV...
https://doi.org/10.1016/j.jcin.2022.01.014
JACC. Cardiovascular Interventions; Simonato M, Vemulapalli S et. al.

Apr 4th, 2022 - Transcatheter aortic valve replacement (TAVR) is the standard of care for severe, symptomatic aortic stenosis. Real-world TAVR data collection contributes to benefit/risk assessment and safety evidence for the U.S. Food and Drug Administration, quality evaluation for the Centers for Medicare and Medicaid Services and hospitals, as well as clinical research and real-world implementation through ...